captopril has been researched along with Diabetes Mellitus, Adult-Onset in 125 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 24 (19.20) | 18.7374 |
1990's | 59 (47.20) | 18.2507 |
2000's | 32 (25.60) | 29.6817 |
2010's | 9 (7.20) | 24.3611 |
2020's | 1 (0.80) | 2.80 |
Authors | Studies |
---|---|
Carvalho, VF; Chaves, ADS; Insuela, DBR; Magalhães, NS; Martins, MA; Silva, PMRE | 1 |
Abouelkheir, M; El-Metwally, TH | 1 |
Abdel-Latif, H; Bassyouni, A; El-Naggar, AR; Elyamany, M; Hassanin, S; Zaafar, D | 1 |
Bult, H; Herijgers, P; Mubagwa, K; Nevelsteen, I; Van den Bergh, A; Van der Mieren, G; Vanderper, A | 1 |
Alikasifoglu, M; Dagdelen, S; Erbas, B; Erbas, T; Hayran, M; Volkan-Salanci, B | 1 |
Baradaran, HR; Khamseh, ME; Safarnejad, B | 1 |
Mirelman, D; Rabinkov, A; Rosenthal, T; Younis, F | 1 |
Felehgari, V; Khazaie, H; Malek-Khosravi, S; Mozafari, H; Rahimi, M; Rahimi, Z; Rezaei, M; Vaisi-Raygani, A; Yari, K | 1 |
Bean, JS; Kassab, GS; Lu, X; Rekhter, MD | 1 |
Barkoudah, E; Danser, AH; Fisher, ND; Hollenberg, NK; Moukarbel, GV; Nussberger, J | 1 |
Fan, X; Harris, RC; Takahashi, T; Wang, S; Yang, H; Yang, S; Zhang, MZ | 1 |
Al-Mulhim, AS; Fouad, AA; Jresat, I; Morsy, MA | 1 |
Caro, JJ; Lee, K | 1 |
Emoto, M; Hosoi, M; Inaba, M; Ishimura, E; Kawagishi, T; Matsumoto, N; Nakatani, T; Nishizawa, Y; Shoji, S; Shoji, T; Taniwaki, H | 1 |
Jacobsen, P; Parving, HH; Pietraszek, L; Rossing, K | 1 |
Kanaki, T; Matsuda, M; Naitoh, T; Tsuruzoe, N; Yotsumoto, T | 1 |
Hedner, T; Lanke, J; Niklason, A; Niskanen, L | 1 |
Brown, P; Dasgupta, T; McGrowder, D; Ragoobirsingh, D | 1 |
Aldington, SJ; Holman, RR; Kohner, EM; Matthews, DR; Stratton, IM | 1 |
Amini, M; Aminian, T; Aminorroaya, A; Gharavi, M; Janghorbani, M; Rezvanian, H | 1 |
Scheen, AJ | 1 |
Aso, Y; Inukai, T; Inukai, Y; Matsutomo, R; Nakamachi, T; Takahashi, K; Takanashi, K; Takebayashi, K; Wakabayashi, S; Yoshida, N | 1 |
Guerrero-Romero, F; Rodríguez-Morán, M | 1 |
Carrera, MJ; Micaló, T; Montanya, E; Pérez-Maraver, M; Sahun, M; Soler, J; Vinzia, C | 1 |
Liu, J; Liu, YH; Yang, L | 1 |
Bertoluci, MC; Oliveira, FR; Schmid, H; Schmidt, A; Thomazelli, FC; Uebel, D | 1 |
Dem'iankova, IuO; Kratnov, AA; Kratnov, AE; Popov, SA | 1 |
Huang, Z; Jansson, L; Sjöholm, A | 2 |
Fisher, ND; Hollenberg, NK; Stankovic, AR | 1 |
Atkinson, AB; Bell, PM; Browne, J; Ennis, CN; Hunter, SJ; McLaughlin, DM; Sheridan, B | 1 |
Flack, JR; Molyneaux, L; Willey, K; Yue, DK | 1 |
Jeandidier, N; Klewansky, M; Pinget, M | 1 |
Bodkin, NL; Hansen, BC | 1 |
Banyai, M; Capek, M; Kautzky-Willer, A; Ludvik, B; Prager, R; Schnack, C | 1 |
Bellini, C; De Mattia, G; Faldetta, MR; Ferri, C; Laurenti, O; Properzi, G; Santucci, A | 1 |
Canessa, ML; DeFronzo, RA; Giordano, M; Matsuda, M; Sanders, L | 1 |
Campese, VM; Huang, TP; Liou, HH | 1 |
Savage, S; Schrier, RW | 1 |
Anichini, R; Bartolomei, G; Boni, C; Ferrannini, E; Sanna, G; Seghieri, G; Yin, W | 2 |
Bolli, GB; Britta, M; Brunetti, P; Perriello, G; Rambotti, AM; Santeusanio, F; Torlone, E | 1 |
Beck-Nielsen, H; Faergeman, O; Gall, MA; Gerdes, LU; Hommel, EE; Lauritzen, M; Mathiesen, ER; Rossing, P; Skøtt, P; Vølund, A | 1 |
Abad, E; Johnston, S; Lucas, A; Reverter, JL; Romero, R; Salinas, I; Sanmarti, A | 1 |
Lacourcière, Y; Nadeau, A; Poirier, L; Tancrède, G | 2 |
Alkharouf, J; Corry, D; Nalinikumari, K; Tuck, M | 1 |
Materson, BJ | 1 |
Cassone-Faldetta, M; De Mattia, G; Ferri, C; Laurenti, O; Piccoli, A; Santucci, A | 1 |
Açbay, O; Altuntaş, Y; Caner, M; Güven, M; Ince, E; Kanigür-Sultuybek, G | 1 |
Canessa, ML; Castellino, P; DeFronzo, RA; Giordano, M; Sanders, LR | 1 |
Czyzyk, A; Jasik, M; Kasperska-Dworak, A | 1 |
Fukunaga, Y; Inoue, D; Koshiyama, H; Maeda, S; Sakaguchi, H | 1 |
Campbell, O; Guasch, A; Macon, E; Nzerue, C; Parham, M; Zayas, CF | 1 |
Carraro, A; Crepaldi, G; Fasoli, G; Frigato, F; Marin, M; Nisti, S; Nosadini, R; Palisi, M; Scognamiglio, R; Virgili, F | 1 |
Dachman, W; Székács, B; Vajo, Z | 1 |
Basalka, E; Fiser, I; Seitl, K; Stanek, B | 1 |
Canessa, ML; Castellino, P; DeFronzo, RA; Giordano, M; Solini, A | 1 |
Phillips, PJ; Popplewell, PY; Tallis, GA | 1 |
Gan, P; Han, Q; Li, J; Xiao, X; Yu, M | 1 |
Kumar, PD; Rajaratnam, K | 1 |
Arrojo Arias, E; Cordero Guevara, J; del Saz Moreno, V; González Castro, ML; Sáez Fernández, A; Sagredo Pérez, J | 1 |
Edwards, EA; Lewis-Barned, NJ; Robertson, MC; Tillmann, HC; Walker, RJ | 1 |
Parving, HH | 1 |
Miser, WF | 1 |
Bermejo, A; Cabo, P; Duarte, J; Gámez, MJ; Martinez, A; Vera, B; Zarzuelo, A | 1 |
Iwamoto, Y; Iwasaki, N; Nanko, H; Wasada, T | 1 |
Grossman, E; Messerli, FH | 1 |
Atkinson, AB; Bell, PM; Ennis, CN; Hunter, SJ; Sheridan, B; Whitehead, HM; Wiggam, MI | 1 |
Chen, D; Gao, Y; Geng, J; Lü, R; Ren, K; Wang, X; Wang, Y; Yu, X; Zhao, J | 1 |
Bauduceau, B; Dupuy, O; Mayaudon, H | 2 |
Botteri, F; Cheung, R; Huff, MW; Lewanczuk, RZ; Muirhead, N; Oddou-Stock, P; Pecher, E; Rodger, NW | 1 |
Alderman, MH; Applegate, WB; Furberg, CD; Pahor, M; Psaty, BM; Williamson, JD | 1 |
Dvorak, SR | 1 |
Coca, A; Ruilope, LM | 1 |
Levinson, PD | 1 |
Ahonen, P; Saltevo, J | 1 |
Hansson, L; Hedner, T; Himmelmann, A | 1 |
Adler, A; Clarke, P; Cull, C; Gray, A; Holman, R; Neil, A; Raikou, M; Stevens, R; Stratton, I | 1 |
Larger, E; Marre, M | 1 |
Carruthers, SG | 1 |
Boner, G; Erman, A; van Dijk, DJ | 1 |
Audi, L; Lucas, A; Romero, R; Salinas, I; Sanmarti, A; Teixidó, J | 1 |
Beck-Nielsen, H; Faergeman, O; Gall, MA; Gerdes, LU; Hommel, E; Lauritzen, M; Mathiesen, ER; Rossing, P; Skøtt, P; Vølund, A | 1 |
Kawai, K; Murayama, Y; Suzuki, S; Watanabe, Y; Yamashita, K | 1 |
Bain, SC; Barnett, AH; Le Guen, CA; Lunec, J | 1 |
Agabiti-Rosei, E; Caldonazzo, A; Cravarezza, P; Giustina, A; Giustina, G; Romanelli, G | 1 |
Sandler, M; Watson, N | 1 |
Bolli, GB; Botta, G; Brunetti, P; Perriello, G; Rambotti, AM; Santeusanio, F; Torlone, E | 1 |
Felip, A; Lucas, A; Romero, R; Salinas, I; Sanmarti, A; Teixidó, J | 1 |
Arauz-Pacheco, C; Ramirez, LC; Raskin, P; Rios, JM | 1 |
Chan, MK; Cheng, IK; Ma, JT; Yeh, GR | 1 |
Bossoni, S; Caldonazzo, A; Cimino, A; Cravarezza, P; Giustina, A; Giustina, G; Romanelli, G | 1 |
Ishii, J; Itabashi, A; Katayama, S; Kawazu, S; Kodama, J; Tanaka, K | 1 |
Hiroto, S; Ishikawa, Y; Kaneko, Y; Miyakawa, T; Shindo, Y; Shionoiri, H; Takasaki, I | 1 |
Scapellato, L; Stornello, M; Valvo, EV | 1 |
Dietze, GJ; Fink, E; Jauch, KW; Mehnert, H; Rett, K; Wicklmayr, M | 1 |
Andonova, K; Koev, D; Zacharieva, S | 1 |
Leone, S; Scapellato, L; Stornello, M; Valvo, EV; Vasques, E | 1 |
Agabiti-Rosei, E; Bossoni, S; Girelli, A; Giustina, A; Giustina, G; Muiesan, G; Muiesan, ML; Romanelli, G | 1 |
Leblanc, H; Marre, M; Passa, P | 1 |
Dietze, G; Fink, E; Jauch, KW; Mehnert, H; Rett, K; Wicklmayr, M | 1 |
Gottlieb, SS; Kessler, PD; Lee, WH; Medina, N; Packer, M; Yushak, M | 1 |
Antiga, L; Bedogna, V; Bommartini, F; Casagrande, P; Maschio, G; Oldrizzi, L; Rugiu, C; Valvo, E; Zamboni, M | 1 |
Dietze, GJ; Rett, K; Wicklmayr, M | 1 |
Aguilar, M; Campos-Pastor, MM; Escobar-Jiminez, F; Fernandez Soto, ML; Garcia del Rio, C; Lobon, JA | 1 |
Dietze, G; Mehnert, H; Rett, K; Tschollar, W; Wicklmayr, M | 1 |
Dietze, G; Guenther, B; Hartl, W; Jauch, KW; Rett, K; Wicklmayr, M | 1 |
Dietze, G; Fink, E; Günther, B; Jauch, KW; Lotz, N; Rett, K; Wicklmayr, M | 1 |
Gómez Reyes, D; Rojas Hidalgo, E | 1 |
Bell, D; Clarke, BF; Collier, A; Matthews, DW; Muir, AL; Wathen, CG | 1 |
Dietze, GJ; Fink, E; Fritz, H; Günther, B; Hartl, W; Jauch, KW; Mehnert, H; Rett, K; Wicklmayr, M | 1 |
Bell, D; Clarke, BF; Collier, A; Matthews, DM; Muir, AL; Roulston, JE; Wathen, CG | 1 |
de la Calle, H; Dominguez, JR; Hurtado, A; Robles, RG; Sancho-Rof, J | 1 |
Benetollo, P; Crepaldi, G; D'Angelo, A; Gambaro, G; Giannini, S; Lavagnini, T; Malvasi, L; Sartori, L | 1 |
Carleo, R; Dell'Aversano, R; Gatti, A; Monda, M | 1 |
Fazzi, L; Ricci, F; Ricci, PD | 1 |
Cicerello, E; Crepaldi, G; D'Angelo, A; Del Turco, M; Gambaro, G; Morbiato, F; Sartori, L | 1 |
9 review(s) available for captopril and Diabetes Mellitus, Adult-Onset
Article | Year |
---|---|
Renin-angiotensin system inhibition prevents type 2 diabetes mellitus. Part 1. A meta-analysis of randomised clinical trials.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Diabetes Mellitus, Type 2; Humans; Hypertension; Randomized Controlled Trials as Topic; Receptor, Angiotensin, Type 1; Renin-Angiotensin System | 2004 |
Renal diseases in diabetes mellitus.
Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Arteriosclerosis; Calcium Channel Blockers; Captopril; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Humans; Peritoneal Dialysis, Continuous Ambulatory; Prognosis; Urinary Tract Infections | 1997 |
Renoprotection in diabetes: genetic and non-genetic risk factors and treatment.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Progression; Glomerular Filtration Rate; Humans; Kidney Failure, Chronic; Risk Factors | 1998 |
Therapeutic benefits of ACE inhibitors and other antihypertensive drugs in patients with type 2 diabetes.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Captopril; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Humans; Hypertension; Randomized Controlled Trials as Topic | 2000 |
ACE inhibitors: new hope for old drugs?
Topics: Angina, Unstable; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Diabetes Mellitus, Type 2; Humans; Myocardial Infarction; Ramipril; Risk Factors | 2000 |
[Renin-angiotensin system blockade reduces cardiovascular mortality and morbidity attributable to arterial hypertension by primary and secondary prevention. The end of the road?].
Topics: Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Cardiovascular Diseases; Clinical Trials as Topic; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Humans; Hypertension; Kidney Diseases; Primary Prevention; Randomized Controlled Trials as Topic; Renin-Angiotensin System; Risk Factors; Time Factors | 2000 |
Beta-blockers, diabetes, and hypoglycemia: risky business?
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Captopril; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Humans; Hypoglycemia; Randomized Controlled Trials as Topic; Risk Factors; Time Factors | 2001 |
The diabetic hypertensive (or hypertensive diabetic)--a compelling need to optimize blood pressure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Humans; Hypertension | 2001 |
[Effect of the angiotensin I-converting enzyme inhibitor captopril in hypertensive diabetics without nephropathy].
Topics: Captopril; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Humans; Hypertension; Male; Middle Aged | 1988 |
57 trial(s) available for captopril and Diabetes Mellitus, Adult-Onset
Article | Year |
---|---|
The Role of Vildagliptin in Treating Hypertension Through Modulating Serum VEGF in Diabetic Hypertensive Patients.
Topics: Adult; Antihypertensive Agents; Biomarkers; Blood Pressure; Captopril; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Egypt; Female; Glycated Hemoglobin; Humans; Hypertension; Insulin Resistance; Lipids; Male; Metformin; Middle Aged; Prospective Studies; Time Factors; Treatment Outcome; Vascular Endothelial Growth Factor A; Vildagliptin | 2019 |
Impact of renin-angiotensin system polymorphisms on renal haemodynamic responsiveness to acute angiotensin-converting enzyme inhibition in type 2 diabetes mellitus.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Diabetes Mellitus, Type 2; Female; Genotype; Hemodynamics; Humans; Kidney; Male; Middle Aged; Peptidyl-Dipeptidase A; Polymorphism, Genetic; Radioisotope Renography; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Technetium Tc 99m Mertiatide | 2009 |
Renal responses to three types of renin-angiotensin system blockers in patients with diabetes mellitus on a high-salt diet: a need for higher doses in diabetic patients?
Topics: Aldosterone; Amides; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Biphenyl Compounds; Blood Pressure; Captopril; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fumarates; Humans; Irbesartan; Kidney; Male; Middle Aged; Renin-Angiotensin System; Sodium Chloride, Dietary; Tetrazoles; Treatment Outcome | 2011 |
Intrarenal hemodynamic changes after captopril test in patients with type 2 diabetes: a duplex Doppler sonography study.
Topics: Adult; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Glycated Hemoglobin; Heart Rate; Humans; Male; Middle Aged; Renal Circulation; Renin; Ultrasonography; Vascular Resistance | 2003 |
Renoprotective effects of adding angiotensin II receptor blocker to maximal recommended doses of ACE inhibitor in diabetic nephropathy: a randomized double-blind crossover trial.
Topics: Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Captopril; Cross-Over Studies; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Double-Blind Method; Drug Therapy, Combination; Enalapril; Female; Humans; Kidney; Lisinopril; Male; Middle Aged; Tetrazoles; Treatment Outcome | 2003 |
Development of diabetes is retarded by ACE inhibition in hypertensive patients--a subanalysis of the Captopril Prevention Project (CAPPP).
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Cohort Studies; Diabetes Mellitus, Type 2; Female; Humans; Hypertension; Male; Middle Aged; Multivariate Analysis; Prospective Studies; Risk Factors | 2004 |
Risks of progression of retinopathy and vision loss related to tight blood pressure control in type 2 diabetes mellitus: UKPDS 69.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Atenolol; Blood Glucose; Blood Pressure; Captopril; Cataract Extraction; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Disease Progression; Female; Humans; Hypertension, Renal; Laser Coagulation; Male; Middle Aged; Prospective Studies; Risk Factors; Vision Disorders; Vitreous Hemorrhage | 2004 |
Comparison of the effect of pentoxifylline and captopril on proteinuria in patients with type 2 diabetes mellitus.
Topics: Adult; Aged; Captopril; Cross-Over Studies; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Humans; Male; Middle Aged; Pentoxifylline; Proteinuria | 2005 |
Pentoxifylline is as effective as captopril in the reduction of microalbuminuria in non-hypertensive type 2 diabetic patients--a randomized, equivalent trial.
Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Captopril; Chi-Square Distribution; Diabetes Mellitus, Type 2; Female; Humans; Male; Middle Aged; Pentoxifylline; Statistics, Nonparametric; Treatment Outcome | 2005 |
Renoprotective effect of diltiazem in hypertensive type 2 diabetic patients with persistent microalbuminuria despite ACE inhibitor treatment.
Topics: Albuminuria; Antihypertensive Agents; Blood Pressure; Captopril; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diltiazem; Drug Therapy, Combination; Female; Glycated Hemoglobin; Humans; Hypertension; Male; Middle Aged; Multivariate Analysis; Prospective Studies | 2005 |
[Clinical observation on treatment of early diabetic nephropathy by milkvetch injection combined with captopril].
Topics: Adult; Aged; Albuminuria; Astragalus propinquus; Captopril; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Drug Therapy, Combination; Drugs, Chinese Herbal; Female; Humans; Injections; Male; Middle Aged; Phytotherapy | 2005 |
Urinary TGF-beta1 reduction related to a decrease of systolic blood pressure in patients with type 2 diabetes and clinical diabetic nephropathy.
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Blood Glucose; Blood Pressure; Captopril; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Drug Therapy, Combination; Enalapril; Female; Follow-Up Studies; Glycated Hemoglobin; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Potassium; Propranolol; Ramipril; Transforming Growth Factor beta1 | 2006 |
[Lisinopril-induced changes in antioxidant defense in patients with acute coronary syndrome and concomitant diabetes mellitus type 2].
Topics: Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Captopril; Catalase; Diabetes Mellitus, Type 2; Disease Progression; Female; Follow-Up Studies; Glutathione Reductase; Humans; Lisinopril; Male; Middle Aged; Myocardial Ischemia; Neutrophils; Oxidative Stress; Oxidoreductases; Peroxidase; Severity of Illness Index; Spectrophotometry; Superoxide Dismutase; Treatment Outcome | 2005 |
Comparison of effects of combined ACE inhibitor and low-dose thiazide diuretic with ACE inhibitor alone on insulin action in patients with hypertension and Type 2 diabetes: a double-blind crossover study.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Bendroflumethiazide; Captopril; Cross-Over Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Double-Blind Method; Drug Therapy, Combination; Glucose Clamp Technique; Humans; Hypertension; Insulin; Insulin Resistance; Middle Aged; Treatment Outcome | 2008 |
Regression of microalbuminuria: results of a controlled study, indapamide versus captopril.
Topics: Aged; Albuminuria; Analysis of Variance; Blood Pressure; Captopril; Diabetes Mellitus, Type 2; Female; Humans; Hypertension; Indapamide; Male; Middle Aged; Radioimmunoassay | 1993 |
Effects of captopril treatment versus placebo on renal function in type 2 diabetic patients with microalbuminuria: a long-term study.
Topics: Aged; Albuminuria; Captopril; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Humans; Longitudinal Studies; Male; Middle Aged; Placebos | 1994 |
Circulating endothelin-1 levels in lean non-insulin-dependent diabetic patients. Influence of ACE inhibition.
Topics: Blood Glucose; Blood Pressure; Body Weight; Captopril; Diabetes Mellitus, Type 2; Double-Blind Method; Endothelins; Humans; Insulin; Male; Middle Aged; Sensitivity and Specificity | 1995 |
Hypertension in Diabetes Study. III. Prospective study of therapy of hypertension in type 2 diabetic patients: efficacy of ACE inhibition and beta-blockade.
Topics: Adult; Aged; Atenolol; Blood Glucose; Blood Pressure; Body Weight; Captopril; Cholesterol; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Follow-Up Studies; Humans; Hypertension; Male; Middle Aged; Prospective Studies; Triglycerides; United Kingdom | 1994 |
Effect of long-term therapy with captopril on proteinuria and renal function in patients with non-insulin-dependent diabetes and with non-diabetic renal diseases.
Topics: Adrenergic beta-Antagonists; Aged; Blood Pressure; Captopril; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diuretics; Drug Administration Schedule; Female; Glomerular Filtration Rate; Humans; Hydralazine; Kidney; Kidney Diseases; Male; Prospective Studies; Proteinuria; Renin | 1995 |
Improved insulin action and glycemic control after long-term angiotensin-converting enzyme inhibition in subjects with arterial hypertension and type II diabetes.
Topics: Aged; Analysis of Variance; Antihypertensive Agents; Blood Glucose; Blood Pressure; Captopril; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diet, Diabetic; Fatty Acids, Nonesterified; Female; Glucose; Glucose Clamp Technique; Glycated Hemoglobin; Humans; Hypertension; Hypoglycemic Agents; Infusions, Intravenous; Insulin; Lipid Metabolism; Male; Middle Aged | 1993 |
[The effect of captopril, metoprolol and hydrochlorothiazide therapy in patients with non-insulin-dependent diabetes (NIDDM) and primary hypertension. A double-blind, randomized cross-over study].
Topics: Aged; Captopril; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Evaluation; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Metoprolol; Middle Aged | 1993 |
Renal function changes in microalbuminuric normotensive type II diabetic patients treated with angiotensin-converting enzyme inhibitors.
Topics: Albuminuria; Blood Glucose; Blood Pressure; Captopril; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diabetic Retinopathy; Diastole; Female; Follow-Up Studies; Glomerular Filtration Rate; Glycated Hemoglobin; Humans; Male; Middle Aged; Renal Circulation; Systole; Triglycerides | 1993 |
Captopril or conventional therapy in hypertensive type II diabetics. Three-year analysis.
Topics: Aged; Albuminuria; Blood Pressure; Captopril; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Kidney; Male; Metoprolol; Middle Aged; Prospective Studies | 1993 |
Long-term effects of the angiotensin converting enzyme inhibitor captopril on metabolic control in non-insulin-dependent diabetes mellitus.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Blood Glucose; Blood Pressure; Captopril; Diabetes Mellitus, Type 2; Female; Humans; Male; Middle Aged; Potassium; Time Factors | 1993 |
Circulating catecholamines and metabolic effects of captopril in NIDDM patients.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Blood Glucose; Captopril; Cross-Over Studies; Diabetes Mellitus, Type 2; Epinephrine; Glucose Clamp Technique; Humans; Infusions, Intravenous; Insulin; Male; Norepinephrine | 1996 |
Effect of alpha-adrenergic blockers, ACE inhibitors, and calcium channel antagonists on renal function in hypertensive non-insulin-dependent diabetic patients.
Topics: Adrenergic alpha-Antagonists; Adult; Angiotensin-Converting Enzyme Inhibitors; Blood Glucose; Blood Pressure; Calcium Channel Blockers; Captopril; Diabetes Mellitus, Type 2; Doxazosin; Female; Glomerular Filtration Rate; Glycated Hemoglobin; Humans; Hypertension; Kidney; Kidney Function Tests; Male; Middle Aged; Nifedipine; Proteinuria | 1996 |
Hypertension in Diabetes Study IV. Therapeutic requirements to maintain tight blood pressure control.
Topics: Adrenergic beta-Antagonists; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Blood Pressure; Captopril; Cohort Studies; Diabetes Mellitus, Type 2; Electrolytes; Female; Follow-Up Studies; Humans; Hypertension; Hypoglycemia; Male; Middle Aged; Prospective Studies; Time Factors | 1996 |
Contrasting effects of calcium channel blockade versus converting enzyme inhibition on proteinuria in African Americans with non-insulin-dependent diabetes mellitus and nephropathy.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Black People; Calcium Channel Blockers; Captopril; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Humans; Isradipine; Longitudinal Studies; Male; Middle Aged; Prospective Studies; Proteinuria | 1997 |
Evaluation of the efficacy and tolerability of nitrendipine in reducing both pressure and left ventricular mass in hypertensive type 2 diabetic patients.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Glucose; Blood Pressure; Calcium Channel Blockers; Captopril; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Evaluation; Drug Tolerance; Echocardiography; Female; Follow-Up Studies; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Nitrendipine; Stroke Volume; Treatment Outcome | 1997 |
Effect of ACE inhibition by benazepril, enalapril and captopril on chronic and post exercise proteinuria.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Captopril; Chronic Disease; Diabetes Mellitus, Type 2; Enalapril; Exercise; Female; Glomerulonephritis; Humans; Male; Proteinuria | 1996 |
Na+/Li+ and Na+/H+ countertransport activity in hypertensive non-insulin-dependent diabetic patients: role of insulin resistance and antihypertensive treatment.
Topics: Adult; Antihypertensive Agents; Antiporters; Blood Pressure; Captopril; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Double-Blind Method; Doxazosin; Erythrocytes; Female; Glucose; Glucose Clamp Technique; Humans; Hypertension; Insulin; Lithium; Male; Middle Aged; Nifedipine; Sodium; Sodium-Hydrogen Exchangers; Triglycerides | 1997 |
A long-term comparison between enalapril and captopril on insulin sensitivity in normotensive non-insulin dependent diabetic volunteers.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Glucose; Captopril; Cross-Over Studies; Diabetes Mellitus, Type 2; Enalapril; Female; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Lipoproteins; Male; Middle Aged; Single-Blind Method; Time Factors | 1997 |
Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group.
Topics: Adrenergic beta-Antagonists; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Blood Glucose; Captopril; Cerebrovascular Disorders; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Retinopathy; Female; Follow-Up Studies; Humans; Hypertension; Hypoglycemia; Male; Middle Aged; Myocardial Infarction; Patient Compliance; Peripheral Vascular Diseases; Prospective Studies; Proteinuria; Visual Acuity; Weight Gain | 1998 |
Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39. UK Prospective Diabetes Study Group.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Captopril; Cerebrovascular Disorders; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Retinopathy; Follow-Up Studies; Glycated Hemoglobin; Humans; Hypertension; Hypoglycemia; Male; Middle Aged; Myocardial Infarction; Patient Compliance; Peripheral Vascular Diseases; Prospective Studies; Treatment Outcome; Visual Acuity; Weight Gain | 1998 |
Cost effectiveness analysis of improved blood pressure control in hypertensive patients with type 2 diabetes: UKPDS 40. UK Prospective Diabetes Study Group.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Captopril; Cost of Illness; Cost-Benefit Analysis; Diabetes Mellitus, Type 2; Female; Health Services; Hospitalization; Humans; Hypertension; Life Expectancy; Male; Middle Aged; Prospective Studies; Quality-Adjusted Life Years; Sensitivity and Specificity; Time Factors; Treatment Outcome; United Kingdom | 1998 |
Comparison of effects of captopril used either alone or in combination with a thiazide diuretic on insulin action in hypertensive Type 2 diabetic patients: a double-blind crossover study.
Topics: Antihypertensive Agents; Benzothiadiazines; Blood Pressure; Captopril; Cross-Over Studies; Diabetes Mellitus, Type 2; Diuretics; Double-Blind Method; Female; Glucose Clamp Technique; Humans; Hypertension; Insulin; Male; Middle Aged; Placebos; Sodium Chloride Symporter Inhibitors | 1999 |
A clinical trial of tang shen ning for treatment of diabetic nephropathy.
Topics: Adult; Aged; Antihypertensive Agents; Captopril; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Drugs, Chinese Herbal; Female; Humans; Male; Middle Aged; Qi; Yin Deficiency | 1998 |
Efficacy of rilmenidine versus captopril on microalbuminuria: a pilot study in hypertensive type 2 diabetics.
Topics: Albuminuria; Antihypertensive Agents; Captopril; Diabetes Mellitus, Type 2; Humans; Hypertension; Oxazoles; Pilot Projects; Random Allocation; Rilmenidine | 1999 |
The effect of valsartan and captopril on lipid parameters in patients with type II diabetes mellitus and nephropathy.
Topics: Adult; Aged; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Humans; Hypertension; Lipids; Male; Middle Aged; Tetrazoles; Valine; Valsartan | 1999 |
Rilmenidine in the hypertensive type-2 diabetic: a controlled pilot study versus captopril.
Topics: Aged; Albuminuria; Antihypertensive Agents; Blood Pressure Determination; Captopril; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Hypertension; Male; Middle Aged; Oxazoles; Pilot Projects; Rilmenidine | 2000 |
An economic evaluation of atenolol vs. captopril in patients with Type 2 diabetes (UKPDS 54).
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Atenolol; Captopril; Confidence Intervals; Cost-Benefit Analysis; Diabetes Mellitus, Type 2; Family Practice; Follow-Up Studies; Glycated Hemoglobin; Hospitalization; Humans; Hypertension; Hypoglycemic Agents; Time Factors; Treatment Outcome; United Kingdom | 2001 |
Should the use of short acting angiotensin-converting enzyme inhibitors be abandoned?
Topics: Adult; Aged; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Captopril; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Enalapril; Humans; Middle Aged; Peptidyl-Dipeptidase A; Renin; Time Factors | 2000 |
Comparative effects of captopril versus nifedipine on proteinuria and renal function of type 2 diabetic patients.
Topics: Blood Glucose; Blood Pressure; Captopril; Diabetes Mellitus, Type 2; Female; Follow-Up Studies; Glycated Hemoglobin; Humans; Kidney Glomerulus; Male; Middle Aged; Nifedipine; Potassium; Proteinuria; Regression Analysis; Serum Albumin; Sodium | 1992 |
Placebo-controlled comparison of captopril, metoprolol, and hydrochlorothiazide therapy in non-insulin-dependent diabetic patients with primary hypertension.
Topics: Aged; Captopril; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Glomerular Filtration Rate; Humans; Hydrochlorothiazide; Hypertension; Hypoglycemic Agents; Lipids; Male; Metoprolol; Middle Aged | 1992 |
Comparison of the effects of nilvadipine and captopril on glucose and lipid metabolism in NIDDM patients with hypertension.
Topics: Analysis of Variance; Apolipoprotein A-I; Apolipoprotein A-II; Apolipoproteins B; Blood Glucose; Blood Pressure; Calcium Channel Blockers; Captopril; Cholesterol; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Heart Rate; Humans; Hypertension; Lipids; Male; Middle Aged; Nifedipine; Pulse | 1992 |
Comparison of the free radical scavenging activity of captopril versus enalapril: a three month in vivo study in hypertensive diabetic patients.
Topics: Adult; Aged; Blood Proteins; Captopril; Diabetes Mellitus, Type 2; Enalapril; Female; Free Radical Scavengers; Free Radicals; Humans; Hypertension; Lipid Peroxides; Male; Middle Aged; Thiobarbiturates | 1991 |
Comparative effects of converting enzyme inhibition and conventional therapy in hypertensive non-insulin dependent diabetics with normal renal function.
Topics: Aged; Albuminuria; Blood Pressure; Captopril; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Glycated Hemoglobin; Humans; Hydrochlorothiazide; Hypertension; Kidney; Male; Middle Aged | 1991 |
Albuminuria induced by exercise in hypertensive type I and type II diabetic patients: a randomised, double-blind study on the effects of acute administration of captopril and nifedipine.
Topics: Adolescent; Adult; Albuminuria; Blood Pressure; Captopril; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dose-Response Relationship, Drug; Double-Blind Method; Exercise; Female; Humans; Hypertension; Male; Middle Aged; Nifedipine; Time Factors | 1991 |
Effects of captopril on glucose tolerance in elderly patients with congestive cardiac failure.
Topics: Aged; Aged, 80 and over; Blood Glucose; Captopril; Diabetes Mellitus, Type 2; Female; Glucose Tolerance Test; Heart Failure; Humans; Male; Prospective Studies | 1991 |
ACE-inhibition increases hepatic and extrahepatic sensitivity to insulin in patients with type 2 (non-insulin-dependent) diabetes mellitus and arterial hypertension.
Topics: Adult; Blood Glucose; Blood Pressure; Captopril; Diabetes Mellitus, Type 2; Fatty Acids, Nonesterified; Female; Glucose; Glucose Clamp Technique; Humans; Hypertension; Insulin; Insulin Infusion Systems; Kinetics; Liver; Male | 1991 |
Comparison of captopril and enalapril in the treatment of hypertension in patients with non-insulin dependent diabetes mellitus and nephropathy.
Topics: Blood Pressure; Captopril; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Enalapril; Female; Humans; Hypertension; Male; Middle Aged | 1990 |
Short-term administration of captopril and nifedipine and exercise-induced albuminuria in normotensive diabetic patients with early-stage nephropathy.
Topics: Administration, Oral; Adolescent; Adult; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Captopril; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Double-Blind Method; Exercise; Female; Humans; Kidney Glomerulus; Male; Middle Aged; Nifedipine | 1990 |
Hemodynamic, renal, and humoral effects of the calcium entry blocker nicardipine and converting enzyme inhibitor captopril in hypertensive type II diabetic patients with nephropathy.
Topics: Adult; Blood Pressure; Captopril; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Drug Combinations; Female; Heart Rate; Hemodynamics; Humans; Kidney; Kidney Function Tests; Male; Nicardipine | 1989 |
Short-term effect of captopril and nifedipine on micro-albuminuria induced by exercise in hypertensive diabetic patients.
Topics: Albuminuria; Captopril; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Drug Evaluation; Exercise; Exercise Test; Humans; Hypertension; Nifedipine | 1989 |
Effect of captopril at two different dosage regimens in hypertensive non-insulin dependent patients.
Topics: Captopril; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Drug Administration Schedule; Female; Humans; Hypertension; Male; Middle Aged; Random Allocation | 1988 |
Role of angiotensin-converting enzyme inhibitors in early antihypertensive treatment in non-insulin dependent diabetes mellitus.
Topics: Aged; Blood Glucose; Captopril; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Humans; Hypertension; Middle Aged; Random Allocation | 1988 |
Captopril enhances insulin responsiveness of forearm muscle tissue in non-insulin-dependent diabetes mellitus.
Topics: Alanine; Blood Glucose; Captopril; Diabetes Mellitus, Type 2; Glucose; Humans; Insulin; Male; Middle Aged; Muscles | 1987 |
59 other study(ies) available for captopril and Diabetes Mellitus, Adult-Onset
Article | Year |
---|---|
Effect of the renin-angiotensin system on the exacerbation of adrenal glucocorticoid steroidogenesis in diabetic mice: Role of angiotensin-II type 2 receptor.
Topics: Alloxan; Animals; Captopril; Corticosterone; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Glucocorticoids; Mice; Renin-Angiotensin System | 2022 |
Dipeptidyl peptidase-4 inhibitors can inhibit angiotensin converting enzyme.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Diabetes Mellitus, Type 2; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Enalapril; Female; Glucagon-Like Peptide 1; Humans; Hypertension; Linagliptin; Peptidyl-Dipeptidase A; Protein Binding; Rats; Rats, Sprague-Dawley; Sitagliptin Phosphate | 2019 |
NO-dependent endothelial dysfunction in type II diabetes is aggravated by dyslipidemia and hypertension, but can be restored by angiotensin-converting enzyme inhibition and weight loss.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Biomarkers; Blood Glucose; Caloric Restriction; Captopril; Combined Modality Therapy; Diabetes Mellitus, Type 2; Disease Models, Animal; Dose-Response Relationship, Drug; Dyslipidemias; Endothelium, Vascular; Female; Hypertension; Leptin; Lipids; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Obese; Nitric Oxide; Receptors, LDL; Time Factors; Vasodilation; Vasodilator Agents; Weight Loss | 2013 |
The effect of captopril on progression of retinopathy in type 2 diabetes.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Body Mass Index; Captopril; Case-Control Studies; Chi-Square Distribution; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Disease Progression; Female; Glycated Hemoglobin; Humans; Male; Middle Aged; Regression Analysis | 2009 |
S-allyl-mercapto-captopril: a novel compound in the treatment of Cohen-Rosenthal diabetic hypertensive rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Captopril; Cysteine; Diabetes Mellitus, Type 2; Diastole; Disulfides; Hypertension; Hypoglycemic Agents; Male; Rats; Rats, Inbred SHR; Sulfinic Acids; Systole | 2010 |
The frequency of factor V Leiden mutation, ACE gene polymorphism, serum ACE activity and response to ACE inhibitor and angiotensin II receptor antagonist drugs in Iranians type II diabetic patients with microalbuminuria.
Topics: Albuminuria; Alleles; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Captopril; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Factor V; Female; Genetic Predisposition to Disease; Humans; Iran; Losartan; Male; Middle Aged; Mutation; Peptidyl-Dipeptidase A; Polymorphism, Genetic; Treatment Outcome | 2011 |
Protein kinase C inhibition ameliorates functional endothelial insulin resistance and vascular smooth muscle cell hypersensitivity to insulin in diabetic hypertensive rats.
Topics: Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Glucose; Blood Pressure; Captopril; Diabetes Mellitus, Type 2; Disease Models, Animal; Dose-Response Relationship, Drug; Endothelial Cells; Femoral Artery; Hypertension; Indoles; Insulin; Insulin Resistance; Male; Maleimides; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Myography; Protein Deficiency; Protein Kinase C; Protein Kinase Inhibitors; Rats; Rats, Sprague-Dawley; Sodium Chloride, Dietary; Telemetry; Time Factors; Vasoconstriction; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents | 2011 |
Role of blood pressure and the renin-angiotensin system in development of diabetic nephropathy (DN) in eNOS-/- db/db mice.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Captopril; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Hydralazine; Hydrochlorothiazide; Mice; Mice, Knockout; Nitric Oxide Synthase Type III; Renin-Angiotensin System; Reserpine | 2012 |
Protective effects of captopril in diabetic rats exposed to ischemia/reperfusion renal injury.
Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Caspase 3; Creatinine; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Fas Ligand Protein; Glutathione; Heme Oxygenase (Decyclizing); Hyperglycemia; Insulin; Insulin-Secreting Cells; Islets of Langerhans; Kidney; Kidney Diseases; Male; Malondialdehyde; Microtubule-Associated Proteins; NF-kappa B; Nitric Oxide; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Survivin; Tumor Necrosis Factor-alpha | 2013 |
[Hypertensive patient with diabetes. "Blood pressure cosmetics" are not enough here].
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Diabetes Mellitus, Type 2; Enalapril; Evidence-Based Medicine; Humans; Hypertension; Treatment Outcome | 2002 |
An economic evaluation of atenolol vs. captopril in patients with type 2 diabetes (UKPDS 24).
Topics: Antihypertensive Agents; Atenolol; Captopril; Diabetes Mellitus, Type 2; Evaluation Studies as Topic; Health Care Costs; Hospitalization; Humans; Randomized Controlled Trials as Topic; United Kingdom | 2002 |
A novel peroxisome proliferator-activated receptor (PPAR)gamma agonist, NIP-222, reduces urinary albumin excretion in streptozotocin-diabetic mice independent of PPARgamma activation.
Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Glucose; Blood Pressure; Body Weight; Captopril; Chromans; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Genes, Reporter; Hypoglycemic Agents; Kidney; Luciferases; Male; Mice; Organ Size; Plasmids; Receptors, Cytoplasmic and Nuclear; Thiazolidinediones; Transcription Factors; Troglitazone; Urodynamics | 2003 |
The effect of nitric oxide on glucose metabolism.
Topics: Animals; Binding, Competitive; Captopril; Cell Membrane; Diabetes Mellitus, Type 2; Dogs; Female; Glucose; In Vitro Techniques; Insulin; Kinetics; Leukocytes, Mononuclear; Male; Nitric Oxide; Nitric Oxide Donors; Receptor, Insulin; S-Nitrosoglutathione | 2004 |
Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers effectively and directly potentiate superoxide scavenging by polymorphonuclear leukocytes from patients with type 2 diabetes mellitus.
Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antioxidants; Ascorbic Acid; Blood Glucose; Captopril; Diabetes Mellitus, Type 2; Female; Free Radical Scavengers; Humans; Imidazoles; In Vitro Techniques; Male; Middle Aged; Neutrophils; Superoxide Dismutase; Superoxides; Tetrazoles; Thiazepines | 2005 |
Vasoactive drugs enhance pancreatic islet blood flow, augment insulin secretion and improve glucose tolerance in female rats.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Biphenyl Compounds; Blood Glucose; Captopril; Diabetes Mellitus, Type 2; Female; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Insulin; Irbesartan; Islets of Langerhans; Pancreas; Pravastatin; Rats; Rats, Wistar; Regional Blood Flow; Sex Factors; Tetrazoles; Vasodilator Agents | 2007 |
Prorenin and angiotensin-dependent renal vasoconstriction in type 1 and type 2 diabetes.
Topics: Adult; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Captopril; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Humans; Male; Middle Aged; p-Aminohippuric Acid; Reference Values; Renal Circulation; Renin; Renin-Angiotensin System; Sodium Chloride; Vasoconstriction | 2006 |
Gender-specific regulation of pancreatic islet blood flow, insulin levels and glycaemia in spontaneously diabetic Goto-Kakizaki rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Glucose; Captopril; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Female; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Insulin; Irbesartan; Islets of Langerhans; Male; Pravastatin; Rats; Rats, Mutant Strains; Regional Blood Flow; Sex Factors; Tetrazoles | 2008 |
Captopril-induced acute pancreatitis.
Topics: Abdominal Pain; Acute Disease; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Humans; Hypertension; Hypoglycemic Agents; Male; Middle Aged; Pancreatitis | 1995 |
Antihypertensive effects of captopril without adverse effects on glucose tolerance in hyperinsulinemic rhesus monkeys.
Topics: Animals; Antihypertensive Agents; Blood Glucose; Blood Pressure; Captopril; Diabetes Mellitus, Type 2; Diastole; Glucose Tolerance Test; Hyperinsulinism; Hypertension; Macaca mulatta; Male; Systole | 1995 |
Effects of angiotensin-converting enzyme inhibitors, Ca2+ channel antagonists, and alpha-adrenergic blockers on glucose and lipid metabolism in NIDDM patients with hypertension.
Topics: Adrenergic alpha-Antagonists; Adult; Angiotensin-Converting Enzyme Inhibitors; Blood Glucose; Blood Pressure; Calcium Channel Blockers; Captopril; Cholesterol; Diabetes Mellitus, Type 2; Doxazosin; Fatty Acids, Nonesterified; Female; Glucose; Glycated Hemoglobin; Humans; Hypertension; Insulin; Lipid Metabolism; Lipids; Male; Middle Aged; Nifedipine | 1995 |
On recent advances in diabetes management.
Topics: Captopril; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Humans; Insulin; Randomized Controlled Trials as Topic | 1994 |
Effect of chronic ACE inhibition on glucose tolerance and insulin sensitivity in hypertensive type 2 diabetic patients.
Topics: Blood Glucose; Blood Pressure; Captopril; Diabetes Mellitus, Type 2; Female; Glucose Tolerance Test; Humans; Hypertension; Insulin; Insulin Resistance; Male; Middle Aged; Potassium | 1994 |
ACE inhibitors as a shield against diabetic nephropathy.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Progression; Enalapril; Humans; Kidney Failure, Chronic | 1996 |
The in vitro effects of captopril on the levels of lipid peroxidation and glutathione of erythrocytes in type II diabetes.
Topics: Adult; Aged; Antihypertensive Agents; Captopril; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Erythrocytes; Glutathione; Humans; Lipid Peroxidation; Middle Aged | 1995 |
Effect of nifedipine, captopril and prazosin on secretory function of pancreatic beta-cells in hypertensive patients with type-2 (non-insulin-dependent) diabetes and in hypertensive non-diabetics.
Topics: Adult; Antihypertensive Agents; Blood Glucose; C-Peptide; Calcium Channel Blockers; Captopril; Diabetes Mellitus, Type 2; Female; Humans; Hypertension; Insulin; Insulin Secretion; Islets of Langerhans; Male; Middle Aged; Nifedipine; Prazosin | 1996 |
Hypoglycemia associated with the administration of angiotensin-converting enzyme inhibitor in a patient with diabetes mellitus.
Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Glucose; Captopril; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Humans; Hypertension; Hypoglycemia; Middle Aged | 1997 |
[The hypertensive type II diabetic patient treated with captopril in free general practice (Austrian Safety Study). An indications study].
Topics: Aged; Antihypertensive Agents; Blood Pressure; Captopril; Diabetes Mellitus, Type 2; Female; Humans; Hypertension; Male; Middle Aged; Product Surveillance, Postmarketing; Quality of Life; Treatment Outcome | 1997 |
The diabetic with renal impairment.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Coma; Diabetic Nephropathies; Humans; Hypertension; Male | 1997 |
Effect of captopril on renal hemodynamics and renal prostaglandins in early type II diabetic patients with normo-or microalbuminuria.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Aged; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Captopril; Diabetes Mellitus, Type 2; Female; Glomerular Filtration Rate; Humans; Male; Matched-Pair Analysis; Middle Aged; Prostaglandins; Renal Plasma Flow; Thromboxane B2 | 1996 |
[The effects of long-term captopril treatment on the evolution of urinary albumin excretion in patients with non-insulin-dependent diabetes mellitus].
Topics: Adult; Aged; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Captopril; Diabetes Mellitus, Type 2; Disease Progression; Female; Follow-Up Studies; Glycated Hemoglobin; Humans; Male; Middle Aged; Prevalence; Time Factors | 1997 |
Antihypertensive therapy in type 2 diabetes mellitus.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Captopril; Diabetes Mellitus, Type 2; Humans; Hypertension; Middle Aged; Patient Selection; Research Design | 1998 |
Cardiovascular effects of captopril and enalapril in obese Zucker rats.
Topics: Acetylcholine; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Blood Pressure; Captopril; Cardiomegaly; Diabetes Mellitus, Type 2; Diaphragm; Enalapril; Female; Glucose; In Vitro Techniques; Insulin; Muscle, Skeletal; Nitroprusside; Norepinephrine; Organ Size; Potassium Chloride; Proteinuria; Rats; Rats, Zucker | 1999 |
Severe protracted lichenoid eruption and hyperuricemia following administration of alacepril.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Diabetes Mellitus, Type 2; Female; Follow-Up Studies; Humans; Hypertension; Lichenoid Eruptions; Uremia; Uric Acid | 1999 |
CAPPP trial. Captopril Prevention Project.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diuretics; Humans; Hypertension | 1999 |
[Difficulties in cleaning molar teeth in patient with type 2 diabetes and enalapril medication].
Topics: Antihypertensive Agents; Captopril; Dental Calculus; Diabetes Mellitus, Type 2; Enalapril; Humans; Hypertension; Male; Middle Aged; Molar; Risk Assessment; Toothbrushing | 1997 |
The Captopril Prevention Project, further analyses on left ventricular hypertrophy and diabetes.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Diabetes Mellitus, Type 2; Humans; Hypertension; Hypertrophy, Left Ventricular; Randomized Controlled Trials as Topic | 2001 |
[Prediction, screening and treatment of renal complications of diabetes].
Topics: Adult; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Cardiovascular Diseases; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diuretics; Female; Glomerular Filtration Rate; Humans; Hypertension; Male; Primary Prevention; Prognosis; Prospective Studies; Proteinuria; Ramipril; Renin-Angiotensin System; Risk Factors; Time Factors | 2001 |
Effect of chronic ACE inhibition on glucose tolerance and insulin sensitivity in hypertensive type 2 diabetic patients.
Topics: Blood Glucose; Blood Pressure; Body Weight; Captopril; Diabetes Mellitus, Type 2; Fasting; Fatty Acids, Nonesterified; Female; Glucose Tolerance Test; Humans; Hypertension; Insulin; Male; Middle Aged; Regression Analysis | 1992 |
Long term follow-up of the effect of captopril on severe proteinuria in hypertensive diabetic patients.
Topics: Adult; Aged; Captopril; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Follow-Up Studies; Humans; Hypertension; Kidney; Male; Middle Aged; Proteinuria; Time Factors | 1990 |
Hypoglycemia induced by angiotensin-converting enzyme inhibitors in patients with non-insulin-dependent diabetes receiving sulfonylurea therapy.
Topics: Captopril; Diabetes Mellitus, Type 2; Enalapril; Glyburide; Humans; Hypertension; Hypoglycemia; Male; Middle Aged | 1990 |
Effect of captopril on glucose concentration. Possible role of augmented postprandial forearm blood flow.
Topics: Blood Glucose; Blood Pressure; Captopril; Diabetes Mellitus, Type 2; Eating; Female; Forearm; Humans; Male; Middle Aged; Regional Blood Flow; Vascular Resistance | 1990 |
Glucose tolerance during chronic captopril therapy in patients with essential hypertension.
Topics: Adult; Blood Glucose; Captopril; Diabetes Mellitus, Type 2; Female; Glucose Tolerance Test; Humans; Hypertension; Male; Metabolic Diseases; Middle Aged | 1987 |
Increased insulin-responsiveness by ACE-inhibition in noninsulin dependent diabetes mellitus.
Topics: Blood Glucose; Blood Pressure; Captopril; Diabetes Mellitus, Type 2; Fatty Acids, Nonesterified; Forearm; Glucose Clamp Technique; Humans; Insulin; Male; Middle Aged; Peptidyl-Dipeptidase A; Regional Blood Flow | 1989 |
Involvement of prostaglandins in the action of captopril in type II diabetic patients.
Topics: 6-Ketoprostaglandin F1 alpha; Aldosterone; Blood Pressure; Captopril; Diabetes Mellitus, Type 2; Dinoprostone; Female; Humans; Male; Middle Aged; Renin; Renin-Angiotensin System; Thromboxane B2 | 1989 |
Systemic and renal effects of chronic angiotensin converting enzyme inhibition with captopril in hypertensive diabetic patients.
Topics: Albuminuria; Blood Pressure; Captopril; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Female; Humans; Hypertension; Kidney; Male; Middle Aged | 1989 |
[Treatment of arterial hypertension in diabetics. Contribution of converting enzyme inhibitors].
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Captopril; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diuretics; Enalapril; Humans; Hypertension; Obesity; Vasodilator Agents | 1985 |
Angiotensin converting enzyme inhibitors in diabetes: experimental and human experience.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Glucose; Bradykinin; Captopril; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Humans; Kinins; Male; Metabolic Clearance Rate; Rats; Rats, Inbred Strains | 1986 |
Influence of diabetes mellitus on changes in left ventricular performance and renal function produced by converting enzyme inhibition in patients with severe chronic heart failure.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Captopril; Diabetes Mellitus, Type 2; Enalapril; Female; Heart Failure; Hemodynamics; Humans; Kidney; Male; Middle Aged; Renin-Angiotensin System | 1987 |
Captopril in patients with type II diabetes and renal insufficiency: systemic and renal hemodynamic alterations.
Topics: Adult; Aged; Captopril; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Hemodynamics; Humans; Hypertension; Kidney; Male; Middle Aged; Proteinuria | 1988 |
Hypoglycemia in hypertensive diabetic patients treated with sulfonylureas, biguanides, and captopril.
Topics: Biguanides; Captopril; Diabetes Mellitus, Type 2; Drug Synergism; Drug Therapy, Combination; Female; Humans; Hypertension; Hypoglycemia; Male; Middle Aged; Sulfonylurea Compounds | 1988 |
[Improved insulin action by ACE inhibition in type-2 diabetics].
Topics: Axilla; Blood Glucose; Captopril; Diabetes Mellitus, Type 2; Drug Evaluation; Drug Synergism; Erythrocytes; Glucose; Hemodynamics; Humans; Insulin; Kinins; Muscles; Receptor, Insulin | 1988 |
The effect of captopril on blood pressure and glucose tolerance in hypertensive non-insulin dependent diabetics.
Topics: Aged; Blood Glucose; Blood Pressure; Captopril; Diabetes Mellitus, Type 2; Female; Glucose Tolerance Test; Humans; Hypertension; Male; Middle Aged | 1986 |
[Captopril in hypertensive patients with type II diabetes mellitus].
Topics: Aged; Blood Glucose; Captopril; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Humans; Hypertension; Male; Middle Aged | 1987 |
The use of captopril and captopril plus frusemide as antihypertensive agents in non-insulin dependent diabetes.
Topics: Blood Glucose; Blood Pressure; Captopril; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Furosemide; Glucose Tolerance Test; Humans; Hypertension; Insulin; Male; Middle Aged | 1987 |
Effect of converting enzyme inhibitors in hypertensive patients with non-insulin-dependent diabetes mellitus.
Topics: Blood Glucose; Blood Pressure; Captopril; Carbohydrate Metabolism; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged | 1986 |
Captopril in the treatment of hypertension in type I and type II diabetic patients.
Topics: Adult; Blood Pressure; Captopril; Carbohydrate Metabolism; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Electrolytes; Female; Humans; Hypertension; Male; Middle Aged | 1986 |
[Effect of captopril on glucose metabolism in hypertensive subjects with type II diabetes mellitus].
Topics: Blood Glucose; Captopril; Diabetes Mellitus, Type 2; Female; Humans; Hypertension; Male; Middle Aged | 1986 |
[Captopril in the control of essential arterial hypertension in diabetic subjects].
Topics: Aged; Captopril; Diabetes Mellitus, Type 2; Female; Humans; Hypertension; Male; Middle Aged; Proline | 1985 |
Captopril in the treatment of hypertension in type I and type II diabetic patients.
Topics: Adult; Captopril; Carbohydrate Metabolism; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Hemodynamics; Humans; Hypertension; Kidney Function Tests; Male; Middle Aged; Renal Circulation | 1985 |